glutarylcarnitine and Inflammation

glutarylcarnitine has been researched along with Inflammation* in 1 studies

Other Studies

1 other study(ies) available for glutarylcarnitine and Inflammation

ArticleYear
Protective effects of L-carnitine on behavioral alterations and neuroinflammation in striatum of glutaryl-COA dehydrogenase deficient mice.
    Archives of biochemistry and biophysics, 2021, 09-30, Volume: 709

    Glutaric acidemia type 1 (GA1) is caused by glutaryl-CoA dehydrogenase deficiency that leads to a blockage in the metabolic route of the amino acids lysine and tryptophan and subsequent accumulation of glutaric acid (GA), 3-hydroxyglutaric acids and glutarylcarnitine (C5DC). Patients predominantly manifest neurological symptoms, associated with acute striatal degeneration, as well as progressive cortical and striatum injury whose pathogenesis is not yet fully established. Current treatment includes protein/lysine restriction and l-carnitine supplementation of (L-car). The aim of this work was to evaluate behavior parameters and pro-inflammatory factors (cytokines IL-1β, TNF-α and cathepsin-D levels), as well as the anti-inflammatory cytokine IL10 in striatum of knockout mice (Gcdh

    Topics: Amino Acid Metabolism, Inborn Errors; Animals; Brain Diseases, Metabolic; Carnitine; Cathepsin D; Corpus Striatum; Glutaryl-CoA Dehydrogenase; Grooming; Inflammation; Interleukin-1beta; Locomotion; Lysine; Mice, Knockout; Neuroprotective Agents; Open Field Test; Transforming Growth Factor beta

2021